新興市場SCV: AVES VS DGSD - ETF
By Xanthe
at 2022-01-20T23:23
at 2022-01-20T23:23
Table of Contents
能納入考慮的新興市場SCV相當有限,以下就針對這兩者進行比較,希望能拋磚引玉。
AVES:Avantis® Emerging Markets Value ETF
https://www.morningstar.com/etfs/arcx/aves/portfolio
美股,Expense Ratio 0.36%
劣勢:
202110上市,實際績效不易評估
美股股息稅30%。若以年配息2.5%計,花費達0.75%
Avg Market Cap = 6.77 Bil,中偏大,規模因子含量較低
部位較集中Taiwan, China, South Korea
優勢:
採Avantis的SCV方法論
成交量20K以上,買賣價差0.2%左右,Total Assets=69.7 Mil,都算OK
DGSD:WisdomTree Emerging Markets SmCp Div ETF (為在美上市DGS的英國版)
https://www.morningstar.com/etfs/xlon/dgsd/portfolio
英股,Expense Ratio 0.54%
劣勢:
高股息策略在反映價值因子上需要打折
成立七年,但每日成交量<1K,買賣價差約為0.75%,Total Assets=37.8 Mil,都須加強
優勢:
已成立七年,長期績效可評估,和其美版的DGS的Total Return幾乎一樣
英股息稅免稅
Avg Market Cap = 1.35 Bil,具備完整規模因子
對Taiwan, China, South Korea的部位集中度較低
--
AVES:Avantis® Emerging Markets Value ETF
https://www.morningstar.com/etfs/arcx/aves/portfolio
美股,Expense Ratio 0.36%
劣勢:
202110上市,實際績效不易評估
美股股息稅30%。若以年配息2.5%計,花費達0.75%
Avg Market Cap = 6.77 Bil,中偏大,規模因子含量較低
部位較集中Taiwan, China, South Korea
優勢:
採Avantis的SCV方法論
成交量20K以上,買賣價差0.2%左右,Total Assets=69.7 Mil,都算OK
DGSD:WisdomTree Emerging Markets SmCp Div ETF (為在美上市DGS的英國版)
https://www.morningstar.com/etfs/xlon/dgsd/portfolio
英股,Expense Ratio 0.54%
劣勢:
高股息策略在反映價值因子上需要打折
成立七年,但每日成交量<1K,買賣價差約為0.75%,Total Assets=37.8 Mil,都須加強
優勢:
已成立七年,長期績效可評估,和其美版的DGS的Total Return幾乎一樣
英股息稅免稅
Avg Market Cap = 1.35 Bil,具備完整規模因子
對Taiwan, China, South Korea的部位集中度較低
--
Tags:
ETF
All Comments
By Ivy
at 2022-01-22T23:34
at 2022-01-22T23:34
By Michael
at 2022-01-24T23:46
at 2022-01-24T23:46
By Mary
at 2022-01-26T23:57
at 2022-01-26T23:57
By Michael
at 2022-01-26T17:44
at 2022-01-26T17:44
By Yedda
at 2022-01-28T17:55
at 2022-01-28T17:55
By Victoria
at 2022-01-26T17:44
at 2022-01-26T17:44
Related Posts
小額定期美股ETF方式請益
By Liam
at 2022-01-19T21:24
at 2022-01-19T21:24
美/英股因子Portfolio請益
By Jacky
at 2022-01-19T13:47
at 2022-01-19T13:47
新北小家庭理財規劃請益
By Edward Lewis
at 2022-01-19T11:21
at 2022-01-19T11:21
投資型保單連結標的 金管會下兩禁令
By Poppy
at 2022-01-17T23:12
at 2022-01-17T23:12
網大推的ETF,實際買單的卻僅僅不到1成?
By Rachel
at 2022-01-17T19:14
at 2022-01-17T19:14